239 related articles for article (PubMed ID: 21672888)
1. Vilazodone for the treatment of depression.
Lindsey WT
Ann Pharmacother; 2011 Jul; 45(7-8):946-53. PubMed ID: 21672888
[TBL] [Abstract][Full Text] [Related]
2. Vilazodone (Viibryd)--a new antidepressant.
Med Lett Drugs Ther; 2011 Jul; 53(1368):53-4. PubMed ID: 21738107
[TBL] [Abstract][Full Text] [Related]
3. Early and sustained improvement with vilazodone in adult patients with major depressive disorder: post hoc analyses of two phase III trials.
Jain R; Chen D; Edwards J; Mathews M
Curr Med Res Opin; 2014 Feb; 30(2):263-70. PubMed ID: 24127687
[TBL] [Abstract][Full Text] [Related]
4. Vilazodone for the treatment of major depressive disorder.
Iranikhah M; Wensel TM; Thomason AR
Pharmacotherapy; 2012 Oct; 32(10):958-65. PubMed ID: 23033234
[TBL] [Abstract][Full Text] [Related]
5. Vilazodone: in major depressive disorder.
Frampton JE
CNS Drugs; 2011 Jul; 25(7):615-27. PubMed ID: 21699273
[TBL] [Abstract][Full Text] [Related]
6. Vilazodone hydrochloride, a combined SSRI and 5-HT1A receptor agonist for major depressive disorder.
Guay DR
Consult Pharm; 2012 Dec; 27(12):857-67. PubMed ID: 23229074
[TBL] [Abstract][Full Text] [Related]
7. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome L
Int J Clin Pract; 2012 Apr; 66(4):356-68. PubMed ID: 22284853
[TBL] [Abstract][Full Text] [Related]
8. Vilazodone: a novel antidepressant.
Choi E; Zmarlicka M; Ehret MJ
Am J Health Syst Pharm; 2012 Sep; 69(18):1551-7. PubMed ID: 22935937
[TBL] [Abstract][Full Text] [Related]
9. A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder.
Robinson DS; Kajdasz DK; Gallipoli S; Whalen H; Wamil A; Reed CR
J Clin Psychopharmacol; 2011 Oct; 31(5):643-6. PubMed ID: 21869687
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder.
Khan A; Cutler AJ; Kajdasz DK; Gallipoli S; Athanasiou M; Robinson DS; Whalen H; Reed CR
J Clin Psychiatry; 2011 Apr; 72(4):441-7. PubMed ID: 21527122
[TBL] [Abstract][Full Text] [Related]
11. Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant.
Laughren TP; Gobburu J; Temple RJ; Unger EF; Bhattaram A; Dinh PV; Fossom L; Hung HM; Klimek V; Lee JE; Levin RL; Lindberg CY; Mathis M; Rosloff BN; Wang SJ; Wang Y; Yang P; Yu B; Zhang H; Zhang L; Zineh I
J Clin Psychiatry; 2011 Sep; 72(9):1166-73. PubMed ID: 21951984
[TBL] [Abstract][Full Text] [Related]
12. Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression.
Khan A
Expert Opin Investig Drugs; 2009 Nov; 18(11):1753-64. PubMed ID: 19764890
[TBL] [Abstract][Full Text] [Related]
13. The effect of vilazodone on sexual function during the treatment of major depressive disorder.
Clayton AH; Kennedy SH; Edwards JB; Gallipoli S; Reed CR
J Sex Med; 2013 Oct; 10(10):2465-76. PubMed ID: 23216998
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
Mathews M; Gommoll C; Chen D; Nunez R; Khan A
Int Clin Psychopharmacol; 2015 Mar; 30(2):67-74. PubMed ID: 25500685
[TBL] [Abstract][Full Text] [Related]
15. Vilazodone approved for major depression.
Traynor K
Am J Health Syst Pharm; 2011 Mar; 68(5):366. PubMed ID: 21330672
[No Abstract] [Full Text] [Related]
16. The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder.
Reed CR; Kajdasz DK; Whalen H; Athanasiou MC; Gallipoli S; Thase ME
Curr Med Res Opin; 2012 Jan; 28(1):27-39. PubMed ID: 22106941
[TBL] [Abstract][Full Text] [Related]
17. Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial.
Rickels K; Athanasiou M; Robinson DS; Gibertini M; Whalen H; Reed CR
J Clin Psychiatry; 2009 Mar; 70(3):326-33. PubMed ID: 19284933
[TBL] [Abstract][Full Text] [Related]
18. Vilazodone: a new treatment option for major depressive disorder.
Owen RT
Drugs Today (Barc); 2011 Jul; 47(7):531-7. PubMed ID: 22013560
[TBL] [Abstract][Full Text] [Related]
19. ACS chemical neuroscience molecule spotlight on viibryd (Vilazodone).
Hopkins CR
ACS Chem Neurosci; 2011 Oct; 2(10):554. PubMed ID: 22860155
[TBL] [Abstract][Full Text] [Related]
20. Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression.
Khan A; Sambunaris A; Edwards J; Ruth A; Robinson DS
Int Clin Psychopharmacol; 2014 Mar; 29(2):86-92. PubMed ID: 24247740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]